We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Letter to the editor regarding "Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial".
- Authors
Atkins, Clarke; Keene, Bruce; DeFrancesco, Teresa C.; Tou, Sandra; Chetboul, Valérie; Côté, Étienne; Ettinger, Stephen; Fox, Philip R.; Hamlin, Robert L.; Mochel, Jonathan P.; Pouchelon, Jean‐Louis; Stepien, Rebecca L.
- Abstract
It would also be relevant to know the number of cases accrued from each institution, as well as the average furosemide dosage, number of dogs receiving spironolactone or doubled ramipril dosage, and how these potential institutional differences were accounted for during data analysis. The manuscript entitled I Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial i 1 reports a study which sought to answer the question "could pimobendan be all that is needed beyond loop diuretics to manage congestive heart failure (CHF) in myxomatous mitral valve disease (MMVD)?" This was done by prospectively comparing the efficacy of pimobendan + ramipril + furosemide (triple treatment) to pimobendan + furosemide (double treatment) to treat new-onset CHF caused by MMVD.
- Subjects
FUROSEMIDE; MITRAL valve; RAMIPRIL; DOGS; SOCIAL degeneration; VALVES; MEDICAL personnel
- Publication
Journal of Veterinary Internal Medicine, 2021, Vol 35, Issue 2, p698
- ISSN
0891-6640
- Publication type
Article
- DOI
10.1111/jvim.16035